Perspectives from CPhI Worldwide - Fleitz and McDonald

Nov 08, 2011
By PharmTech Editors

Fred Fleitz
Roger McDonald


Fred Fleitz,
senior manager, process R&D,
Cambridge Major Laboratories

Roger McDonald,
director, business development,
Cambridge Major Laboratories


Add this Podcast feed to your media player


Patricia Van Arnum, senior editor of Pharmaceutical Technology, speaks with Fred Fleitz, senior manager, process R&D with Cambridge Major Laboratories, and Roger McDonald, director of business development with Cambridge Major Laboratories, on recent project work in optimizing several API syntheses. Fleitz discusses the approach taken in a condensation reaction between a naphthoquinone derivative and a substituted methyl vinyl ketone. McDonald discusses the optimization of a synthetic route for a complex natural product analogue. In another project, he discusses an approach taken to maintain the desired enantioselectivity of a molecule containing a chiral cyclopropane moiety during scale-up (Posted November 2011).